DE3231087C2 - - Google Patents

Info

Publication number
DE3231087C2
DE3231087C2 DE19823231087 DE3231087A DE3231087C2 DE 3231087 C2 DE3231087 C2 DE 3231087C2 DE 19823231087 DE19823231087 DE 19823231087 DE 3231087 A DE3231087 A DE 3231087A DE 3231087 C2 DE3231087 C2 DE 3231087C2
Authority
DE
Germany
Prior art keywords
fraction
substance
nucleic acid
cells
tumor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE19823231087
Other languages
German (de)
English (en)
Other versions
DE3231087A1 (de
Inventor
Yoshio Furutani
Hiroshi Yamamoto
Tamotsu Fukuda
Shizuo Shimada
Osamu Mobara Chiba Jp Yano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsui Toatsu Chemicals Inc
Original Assignee
Mitsui Toatsu Chemicals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsui Toatsu Chemicals Inc filed Critical Mitsui Toatsu Chemicals Inc
Priority to DE19823231087 priority Critical patent/DE3231087A1/de
Publication of DE3231087A1 publication Critical patent/DE3231087A1/de
Application granted granted Critical
Publication of DE3231087C2 publication Critical patent/DE3231087C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE19823231087 1982-08-20 1982-08-20 Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel Granted DE3231087A1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19823231087 DE3231087A1 (de) 1982-08-20 1982-08-20 Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19823231087 DE3231087A1 (de) 1982-08-20 1982-08-20 Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel

Publications (2)

Publication Number Publication Date
DE3231087A1 DE3231087A1 (de) 1984-02-23
DE3231087C2 true DE3231087C2 (enrdf_load_stackoverflow) 1987-08-06

Family

ID=6171365

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823231087 Granted DE3231087A1 (de) 1982-08-20 1982-08-20 Thermisch denaturierte desoxyribonucleinsaeure md-011, verfahren zu deren herstellung und diese enthaltendes antitumormittel

Country Status (1)

Country Link
DE (1) DE3231087A1 (enrdf_load_stackoverflow)

Also Published As

Publication number Publication date
DE3231087A1 (de) 1984-02-23

Similar Documents

Publication Publication Date Title
DE2954387C2 (de) Die tumorspezifische Immunität vergrößernder Bakterienzellenextrakt und Verfahren zu seiner Herstellung
DE3407823C2 (enrdf_load_stackoverflow)
DE2331144A1 (de) Wasserloesliche extrakte von mycobacterien
DE1803987A1 (de) Neues,physiologisch wirksames Peptidolipid und Verfahren zu seiner Herstellung
DE2457090C2 (de) Verfahren zur Herstellung von Impfstoffen sowie Antibronchialimpfstoff
DE2731570C3 (de) Verfahren zur Gewinnung eines Polysaccharide mit therapeutischer Wirkung
DE2930604A1 (de) Doppelstrangige ribonucleinsaeure, verfahren zu ihrer herstellung und diese enthaltende interferon-induktoren
DE2723451C2 (enrdf_load_stackoverflow)
DE1617397C3 (de) Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus
DE3541044A1 (de) Neues, allgemein anwendbares antigen (psc-a) gegen pseudomonas aeruginosa, das als mittel zum schutz gegen pseudomonas aeruginosa-infektion wirkt
DE3780843T2 (de) Industrielles verfahren zur herstellung ribosomaler impfstoffe und die so erhaltenen ribosomalen impfstoffe.
DE3231087C2 (enrdf_load_stackoverflow)
DE2048848A1 (de) Verfahren zur Herstellung eines Korn plexes aus RNS und Polysacchand, Verfahren zur Gewinnung der Polysacchand Komponente und ihre Verwendung zur Herstellung von Arzneimitteln
US4579941A (en) Thermally-denatured deoxyribonucleic acid MD-011 and antitumor agent
DD222895A5 (de) Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids
DE2166462A1 (de) 7 beta -(d-5-amino-5-carboxyvaleramido)3-(alpha-methoxycinnamoyloxymethyl)-7-methoxy-3-cephem-4-carbonsaeure-verbindungen, verfahren zu ihrer herstellung und solche verbindungen enthaltende arzneimittel
DE2403733A1 (de) Neue lipopolysaccharide und verfahren zu ihrer herstellung
DE3015030C2 (enrdf_load_stackoverflow)
DE1617659A1 (de) Polynucleotide,welche als die Interferonerzeugung in lebenden tierischen Zellen induzierende Verbindungen wirksam sind
DE2756851A1 (de) Adjuvantien unspezifischer immunitaet
DE3048699C2 (de) Immuntherapeutisches Mittel gegen Tumore, enthaltend als wirksame Komponente ein Lipopolysaccharid
CA1190164A (en) Thermally-denatured deoxyribonucleic acid md-o11 and antitumor agent
DE1667885A1 (de) Verfahren zur Herstellung von Antitumorsubstanzen
DE3323093A1 (de) Pharmazeutisches praeparat
DE2921829A1 (de) Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee